Skip to main navigation Skip to search Skip to main content

Should GLP-1 agonists be considered an alternative or adjunct to pediatric metabolic and bariatric surgery? more questions than answers

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)117-120
Number of pages4
JournalSurgery for Obesity and Related Diseases
Volume21
Issue number2
DOIs
StatePublished - Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bariatric
  • GLP-1
  • Obesity
  • Pediatric
  • Pharmacotherapy

PubMed: MeSH publication types

  • Journal Article

Cite this